Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

被引:86
作者
Bolin, LM [1 ]
Strycharska-Orczyk, I [1 ]
Murray, R [1 ]
Langston, JW [1 ]
Di Monte, D [1 ]
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
关键词
gliosis; interleukin-6; MPTP; neuroinflammation; Parkinson's disease;
D O I
10.1046/j.1471-4159.2002.01131.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To test the hypothesis that neuroinflammation contributes to dopaminergic neuron death in the MPTP-lesioned mouse, we compared nigrostriatal degeneration in interleukin (IL)-6 (+/+) with IL-6 (-/-) mice. In the absence of IL-6, a single injection of MPTP (30 mg/kg) resulted in significantly greater striatal dopamine depletion than that measured in IL-6 (+/+) mice. The observed dopamine depletion was MPTP dose dependent. This loss of striatal dopamine and a significantly greater loss of TH+ cells in the substantia nigra pars compacta in IL-6 (-/-) mice as compared with control IL-6 (+/+) mice, suggest that IL-6 is neuroprotective in the MPTP-lesioned nigrostriatal system. Co-localization experiments identified striatal astrocytes as the source of IL-6 in IL-6 (+/+) mice at 1 and 7 days postinjection of MPTP. The increased sensitivity of dopaminergic neurons to neurotoxicant in the absence of IL-6, is compatible with a neuroprotective activity of IL-6 in the injured nigrostriatal system.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 72 条
[1]  
ADERKA D, 1989, J IMMUNOL, V143, P3517
[2]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[3]   INTERLEUKIN-6 IN CLINICAL MEDICINE [J].
BAUER, J ;
HERRMANN, F .
ANNALS OF HEMATOLOGY, 1991, 62 (06) :203-210
[4]   NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD [J].
BAZAN, JF .
NEURON, 1991, 7 (02) :197-208
[5]  
Bhat NR, 1998, J NEUROSCI, V18, P1633
[6]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[7]   MICROGLIAL-PRODUCED NITRIC-OXIDE AND REACTIVE NITROGEN-OXIDES MEDIATE NEURONAL CELL-DEATH [J].
BOJE, KM ;
ARORA, PK .
BRAIN RESEARCH, 1992, 587 (02) :250-256
[8]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[9]  
Chan P, 1997, J PHARMACOL EXP THER, V280, P439
[10]  
CHAO CC, 1992, J IMMUNOL, V149, P2736